- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x JCW: 2-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-4-carboxamide(Non-covalent)
- 31 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 6 residues within 4Å:- Chain A: K.59, E.66, D.68, R.114, S.141
- Chain B: R.139
Ligand excluded by PLIPEDO.3: 8 residues within 4Å:- Chain A: A.109, Y.110, S.111, S.112, M.143
- Chain B: Q.55, V.70, L.119
Ligand excluded by PLIPEDO.4: 6 residues within 4Å:- Chain A: D.68, R.114, Q.117, R.139, S.141
- Chain E: R.114
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: P.38, W.103, Y.166
- Chain B: K.27, R.96, I.123
Ligand excluded by PLIPEDO.6: 7 residues within 4Å:- Chain A: K.42, S.167, E.170, E.210
- Chain B: D.94, R.96
- Ligands: JCW.1
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: L.46, T.47, W.77, K.78
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain B: K.59, E.66, D.68, R.114, S.141
- Chain C: R.139
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain B: A.109, Y.110, S.111, S.112
- Chain C: Q.55, V.70, L.119, A.137
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: R.114
- Chain B: D.68, R.114, R.139, S.141
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain B: P.38, W.103, Y.166
- Chain C: R.96, I.123
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain B: K.42, S.167, E.170, E.210
- Chain C: D.94, R.96
- Ligands: JCW.9
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain B: L.46, T.47, W.77, K.78
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain C: K.59, E.66, D.68, R.114, S.141
- Chain D: R.139
Ligand excluded by PLIPEDO.19: 8 residues within 4Å:- Chain C: A.109, Y.110, S.111, S.112, M.143
- Chain D: Q.55, V.70, L.119
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain B: R.114
- Chain C: D.68, R.114, R.139, S.141
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain C: P.38, W.103, Y.166
- Chain D: R.96, I.123
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain C: K.42, S.167, E.170, E.210
- Chain D: D.94, R.96
- Ligands: JCW.17
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain C: L.46, T.47, W.77, K.78
Ligand excluded by PLIPEDO.24: 5 residues within 4Å:- Chain C: E.73, Q.75, I.107, P.136, Q.138
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain D: K.59, E.66, D.68, R.114, S.141
- Chain E: R.139
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain D: A.109, Y.110, S.111, S.112
- Chain E: Q.55, V.70, A.137
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain C: R.114
- Chain D: D.68, R.114, R.139, S.141
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain D: P.38, W.103, Y.166
- Chain E: R.96
Ligand excluded by PLIPEDO.31: 7 residues within 4Å:- Chain D: K.42, S.167, E.170, E.210
- Chain E: D.94, R.96
- Ligands: JCW.26
Ligand excluded by PLIPEDO.32: 4 residues within 4Å:- Chain D: L.46, T.47, W.77, K.78
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain E: K.59, D.61, E.66, R.114, S.141
Ligand excluded by PLIPEDO.36: 7 residues within 4Å:- Chain A: Q.55, V.70, L.119
- Chain E: A.109, Y.110, S.111, S.112
Ligand excluded by PLIPEDO.37: 6 residues within 4Å:- Chain D: R.114
- Chain E: D.68, R.114, Q.117, R.139, S.141
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain A: R.96, I.123
- Chain E: P.38, W.103, Y.166
Ligand excluded by PLIPEDO.39: 7 residues within 4Å:- Chain A: D.94, R.96
- Chain E: K.42, S.167, E.170, E.210
- Ligands: JCW.34
Ligand excluded by PLIPEDO.40: 4 residues within 4Å:- Chain E: L.46, T.47, W.77, K.78
Ligand excluded by PLIP- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 2 residues within 4Å:- Chain A: G.90, N.91
No protein-ligand interaction detected (PLIP)NAG.16: 2 residues within 4Å:- Chain B: G.90, N.91
No protein-ligand interaction detected (PLIP)NAG.25: 1 residues within 4Å:- Chain C: N.91
No protein-ligand interaction detected (PLIP)NAG.33: 3 residues within 4Å:- Chain D: N.87, G.90, N.91
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.91
NAG.41: 2 residues within 4Å:- Chain E: G.90, N.91
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.91
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bueno, R.V. et al., Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. Acta Crystallogr.,Sect.D (2022)
- Release Date
- 2020-03-18
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x JCW: 2-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-4-carboxamide(Non-covalent)
- 31 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bueno, R.V. et al., Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. Acta Crystallogr.,Sect.D (2022)
- Release Date
- 2020-03-18
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E